339 related articles for article (PubMed ID: 30925751)
1. Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.
Stevens M; Oltean S
Cells; 2019 Mar; 8(4):. PubMed ID: 30925751
[TBL] [Abstract][Full Text] [Related]
2. VEGF-A splice variants bind VEGFRs with differential affinities.
Mamer SB; Wittenkeller A; Imoukhuede PI
Sci Rep; 2020 Sep; 10(1):14413. PubMed ID: 32879419
[TBL] [Abstract][Full Text] [Related]
3. Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia.
Hulse RP; Beazley-Long N; Hua J; Kennedy H; Prager J; Bevan H; Qiu Y; Fernandes ES; Gammons MV; Ballmer-Hofer K; Gittenberger de Groot AC; Churchill AJ; Harper SJ; Brain SD; Bates DO; Donaldson LF
Neurobiol Dis; 2014 Nov; 71():245-59. PubMed ID: 25151644
[TBL] [Abstract][Full Text] [Related]
4. The splice variants of vascular endothelial growth factor (VEGF) and their receptors.
Robinson CJ; Stringer SE
J Cell Sci; 2001 Mar; 114(Pt 5):853-65. PubMed ID: 11181169
[TBL] [Abstract][Full Text] [Related]
5. VEGF
Boudria A; Abou Faycal C; Jia T; Gout S; Keramidas M; Didier C; Lemaître N; Manet S; Coll JL; Toffart AC; Moro-Sibilot D; Albiges-Rizo C; Josserand V; Faurobert E; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2019 Feb; 38(7):1050-1066. PubMed ID: 30194450
[TBL] [Abstract][Full Text] [Related]
6. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.
Saito T; Takeda N; Amiya E; Nakao T; Abe H; Semba H; Soma K; Koyama K; Hosoya Y; Imai Y; Isagawa T; Watanabe M; Manabe I; Komuro I; Nagai R; Maemura K
FEBS Lett; 2013 Jul; 587(14):2179-85. PubMed ID: 23711375
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.
Shibuya M
BMB Rep; 2008 Apr; 41(4):278-86. PubMed ID: 18452647
[TBL] [Abstract][Full Text] [Related]
9. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.
Hornig C; Barleon B; Ahmad S; Vuorela P; Ahmed A; Weich HA
Lab Invest; 2000 Apr; 80(4):443-54. PubMed ID: 10780661
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici CS; Boşca AB; Şuşman S; Mărginean M; Mihu C; Istrate M; Moldovan IM; Roman AL; Mihu CM
Rom J Morphol Embryol; 2018; 59(2):455-467. PubMed ID: 30173249
[TBL] [Abstract][Full Text] [Related]
12. Alternative Splicing in Angiogenesis.
Bowler E; Oltean S
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027366
[TBL] [Abstract][Full Text] [Related]
13. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
Salven P; Hattori K; Heissig B; Rafii S
FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
[TBL] [Abstract][Full Text] [Related]
15. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
Takahashi H; Shibuya M
Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
[TBL] [Abstract][Full Text] [Related]
16. Evidence for Pro-angiogenic Functions of VEGF-Ax.
Xin H; Zhong C; Nudleman E; Ferrara N
Cell; 2016 Sep; 167(1):275-284.e6. PubMed ID: 27662093
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.
Peach CJ; Mignone VW; Arruda MA; Alcobia DC; Hill SJ; Kilpatrick LE; Woolard J
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690653
[TBL] [Abstract][Full Text] [Related]
18. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
[TBL] [Abstract][Full Text] [Related]
19. A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2.
Cébe Suarez S; Pieren M; Cariolato L; Arn S; Hoffmann U; Bogucki A; Manlius C; Wood J; Ballmer-Hofer K
Cell Mol Life Sci; 2006 Sep; 63(17):2067-77. PubMed ID: 16909199
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
